Nursing Medical News about Sporotrichosis Potassium Iodide

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Use of Antiemetic Agents in Acute Gastroenteritis

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Oral potassium iodide for the treatment of sporotrichosis
Cochrane Reviews, 10/26/09

Xue S et al. – Potassium iodide is an anti–fungal drug listed in the World Health Organization (WHO) essential drug list and generally thought to be the first choice for cutaneous sporotrichosis including fixed and lymphocutaneous types, in developing countries. No randomised controlled trials (RCTs) of oral potassium iodide versus placebo were found and thus its efficacy and safety could not be analysed in this review. There is a need for randomised placebo controlled trials of oral potassium iodide in this area.

<< Previous
Alternative Dosage of Zidovudine in Infants Exposed to Maternal...

Next >>
Arsenic exposure predicts bladder cancer survival in a US...